cochleated influenza vaccine (Aquarius Biotechnologies)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecochleated influenza vaccine (Aquarius Biotechnologies)
Drug Alias Nameoral cochleate formulation vaccines (Aquarius)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulatorsNeuraminidase modulators
TargetsNeuraminidaseInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAquarius BioTechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAquarius BioTechnologies Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A